Drug Type Bispecific antibody |
Synonyms antibody-100, ABGN-100 |
Target |
Mechanism EpCAM inhibitors(Epithelial cell adhesion molecule inhibitors), TCR modulators(T-cell receptor modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Discovery | US | - |